Literature DB >> 16204351

A Caenorhabditis elegans Parkin mutant with altered solubility couples alpha-synuclein aggregation to proteotoxic stress.

Wolfdieter Springer1, Thorsten Hoppe, Enrico Schmidt, Ralf Baumeister.   

Abstract

Mutations in the human parkin gene encoding an E3 ubiquitin ligase have been associated with early-onset recessive forms of Parkinson's disease (PD). However, the molecular mechanisms by which mutations in the parkin gene cause PD are still under debate. Here, we identified and characterized the Caenorhabditis elegans parkin homolog, pdr-1. PDR-1 protein physically associates and cooperates with a conserved degradation machinery to mediate ubiquitin conjugation. Strikingly, in contrast to pdr-1 loss-of-function mutants, an in-frame deletion variant with altered solubility and intracellular localization properties is hypersensitive toward different proteotoxic stress conditions. Both endoplasmic reticulum-derived folding stress and cytosolic stress conferred by expression of mutant human alpha-synuclein resulted in severe developmental defects and lethality in pdr-1(lg103) mutant background. Furthermore, we show that the corresponding truncated protein PDR-1(Deltaaa24-247) aggregates in cell culture, but still interacts with its ubiquitylation co-enzymes. Thus, it might block the cellular degradation/detoxification machinery and therefore renders worms highly vulnerable to protein folding stress. In contrast to other complete gene knockouts or RNAi models of Parkin function, this C. elegans model recapitulates Parkin insolubility and aggregation similar to several autosomal recessive juvenile parkinsonism (AR-JP)-linked Parkin mutations. We suggest that such Parkin variants that either confer a neomorphic function or a partial loss-of-function may help to further elucidate the biological function of Parkin in vivo and the pathogenic mechanisms resulting in AR-JP. Due to high-throughput capacity of C. elegans, this model is particularly well suited to identify genetic and chemical modifiers of toxicity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16204351     DOI: 10.1093/hmg/ddi371

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  44 in total

1.  Traversing a wormhole to combat Parkinson's disease.

Authors:  Guy A Caldwell; Kim A Caldwell
Journal:  Dis Model Mech       Date:  2008 Jul-Aug       Impact factor: 5.758

2.  RBR ubiquitin ligases: Diversification and streamlining in animal lineages.

Authors:  Ignacio Marín
Journal:  J Mol Evol       Date:  2009-06-13       Impact factor: 2.395

3.  α-synuclein expression from a single copy transgene increases sensitivity to stress and accelerates neuronal loss in genetic models of Parkinson's disease.

Authors:  Jason F Cooper; Katie K Spielbauer; Megan M Senchuk; Saravanapriah Nadarajan; Monica P Colaiácovo; Jeremy M Van Raamsdonk
Journal:  Exp Neurol       Date:  2018-09-05       Impact factor: 5.330

Review 4.  Role of the ubiquitin-proteasome system in nervous system function and disease: using C. elegans as a dissecting tool.

Authors:  Márcio S Baptista; Carlos B Duarte; Patrícia Maciel
Journal:  Cell Mol Life Sci       Date:  2012-03-03       Impact factor: 9.261

5.  Loss of pdr-1/parkin influences Mn homeostasis through altered ferroportin expression in C. elegans.

Authors:  Sudipta Chakraborty; Pan Chen; Julia Bornhorst; Tanja Schwerdtle; Fabian Schumacher; Burkhard Kleuser; Aaron B Bowman; Michael Aschner
Journal:  Metallomics       Date:  2015-03-13       Impact factor: 4.526

6.  Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson's disease. Variability in familial Parkinson's disease.

Authors:  K Markopoulou; D W Dickson; R D McComb; Z K Wszolek; L Katechalidou; L Avery; M S Stansbury; B A Chase
Journal:  Acta Neuropathol       Date:  2008-04-04       Impact factor: 17.088

7.  Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans.

Authors:  Alexandre Benedetto; Catherine Au; Daiana Silva Avila; Dejan Milatovic; Michael Aschner
Journal:  PLoS Genet       Date:  2010-08-26       Impact factor: 5.917

8.  Global microRNA expression profiling of Caenorhabditis elegans Parkinson's disease models.

Authors:  Suvi Asikainen; Martina Rudgalvyte; Liisa Heikkinen; Kristiina Louhiranta; Merja Lakso; Garry Wong; Richard Nass
Journal:  J Mol Neurosci       Date:  2010-01-21       Impact factor: 3.444

9.  Early-life exposure to methylmercury in wildtype and pdr-1/parkin knockout C. elegans.

Authors:  Ebany J Martinez-Finley; Sudipta Chakraborty; James C Slaughter; Michael Aschner
Journal:  Neurochem Res       Date:  2013-04-23       Impact factor: 3.996

10.  SnAvi--a new tandem tag for high-affinity protein-complex purification.

Authors:  Ursula Schäffer; Andreas Schlosser; Kristian M Müller; Angelika Schäfer; Nenad Katava; Ralf Baumeister; Ekkehard Schulze
Journal:  Nucleic Acids Res       Date:  2010-01-04       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.